Physician profile
Howard Haverty
NPI 1942202882
$4,981.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $428 · 2021: $1,021 · 2022: $1,371 · 2023: $1,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,282.87 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $576.10 | 2019-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $455.10 | 2019-2023 | Entyvio, Gattex |
| Genzyme Corporation | $323.79 | 2022-2023 | |
| Janssen Biotech, INC. | $319.25 | 2019-2023 | Stelara |
| Merck Sharp & Dohme LLC | $249.40 | 2019-2023 | Dificid |
| Pfizer INC. | $203.02 | 2019-2023 | |
| Celgene Corporation | $135.59 | 2021-2023 | Zeposia |
| Ironwood Pharmaceuticals, INC | $65.29 | 2020-2023 | Linzess |
| Echosens North America, INC. | $62.25 | 2020 | |
| Nestle Healthcare Nutrition INC. | $59.98 | 2021-2023 | |
| Qol Medical, LLC | $45.42 | 2020-2022 | |
| Braintree Laboratories, INC. | $44.44 | 2019-2021 | |
| Shire North American Group INC | $42.29 | 2019 | |
| Ferring Pharmaceuticals INC. | $36.20 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $28.79 | 2022-2023 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $24.82 | 2022 | |
| Allergan, INC. | $15.53 | 2020 | |
| Alnylam Pharmaceuticals INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Haverty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.